semaglutide supply shortage news november 2025 Ozempic and Wegovy are no longer in shortage, FDA says Novo Nordisk's semaglutide shortage officially

Many people wonder: When should I increase my GLP-1 dose

The study also reported that: 86.4% of participants receiving semaglutide lost at least 5% of their starting weight 69.1% lost at least 10% 50.5% lost at least 15% These figures are trial averages and should not be interpreted as guaranteed individual results

Furthermore, Merriman et al

The cards reduce copays for approved prescriptions but don't replace coverage

For patients comparing costs across all options, our guide on affordable tirzepatide options provides a comprehensive pricing overview

GLP-1 receptor agonist medicines, also called incretin mimetics, are a type of incretin-based medicine for type 2 diabetes